Agoracom: Small Cap Investment - Mosaic ImmunoEngineering Inc. - "We expect PDS will fund its operations through licensing revenue."

Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Reply New Message

Back To Forum List View

gcduck

Rank: President [?]

Points: 12254 [?]

Votes: 135 Score: 3.3 [?]

Your Vote:

Please Log In to Vote

Did you know? You can earn activity points by filling your profile with information about yourself (what city you live in, your favorite team, blogs etc.)

"We expect PDS will fund its operations through licensing revenue."

posted on Oct 17, 2011 04:56PM

To me this is a very positive sign regarding future licensing activity because at an other place the 10Q says the MMP is the only cash resource, hence, not to fund PDS' operations sounds like they are expecting incoming revenues SOON.

I expect that at least some of the companies which licensed the Core Flash Portfolio will soon be announced as new MMP licensees.

BUT: Where's APple?

GLTA

13 Recommendations

Re: "We expect PDS will fund its operations through licensing revenue."

shboomer

Oct 17, 2011 05:01PM

Re: "We expect PDS will fund its operations through licensing revenue."

MagnusBuchs

Oct 17, 2011 05:11PM

Re: "We expect PDS will fund its operations through licensing revenue."

mikesmark